Safety and pharmacokinetics of oseltamivir at standard and high dosages
- 31 May 2010
- journal article
- research article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 35 (5) , 461-467
- https://doi.org/10.1016/j.ijantimicag.2009.12.023
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Pharmacokinetics of High-Dose Oseltamivir in Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2009
- Update on Avian Influenza A (H5N1) Virus Infection in HumansNew England Journal of Medicine, 2008
- Recommendations for the Standardization and Interpretation of the ElectrocardiogramCirculation, 2007
- Neuraminidase Inhibitors for InfluenzaNew England Journal of Medicine, 2005
- Safety and Pharmacology of Oseltamivir in Clinical UseDrug Safety, 2003
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Risk of torsades de pointes with non-cardiac drugsBMJ, 2000
- Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute InfluenzaJAMA, 2000
- Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802Clinical Pharmacokinetics, 1999
- Rate-corrected QT interval: Techniques and limitationsThe American Journal of Cardiology, 1993